Graph Therapeutics raises $5M, total over $10M

Graph Therapeutics secured a $5 million investment led by Daphni, bringing total funding to over $10 million. The techbio company uses a lab-in-the-loop AI platform to decode immune dysfunction from patient tissue. The capital will advance its internal pipeline for inflammatory and immune-mediated diseases.